Latest news
Sugar substitutes were sold as metabolic shortcuts. The evidence is getting harder to ignore
A new review and meta-analysis in Current Atherosclerosis Reports found that non-nutritive sweeteners may not be metabolically inert. Across randomised trials and observational evidence, artificial and low-calorie sweeteners were linked to signals of disrupted glucose-insulin regulation, microbiome changes and higher cardiometabolic risk. The policy problem is not whether sugar is healthy. It is whether “sugar-free”…
WHA 2026: WHO resolution moves precision medicine onto the global health policy agenda
ASCO 2026: Pancreatic cancer gets its precision medicine moment
ASCO 2026: GI cancers are finally moving out of oncology’s blind spot
ASCO 2026: AI is entering cancer care before the rules are ready
ASCO 2026: Are we overtreating cancer?
ASCO 2026: Why oncology is also paying attention to GLP-1 medicines
Regulators Start Writing the Rules for AI-Driven Medicines
AI Pathology Moves From Demo to Workflow
FDA Puts AI Inside the Evidence Machine
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.